Revolution Medicines plans European rollout of pancreatic cancer drug
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
Open on the live globe →Who reported it
- 2026-10-16 08:48 UTCCyprus Mail · cyprus-mail.com ↗
- 2026-10-16 13:38 UTCSTAT · statnews.com ↗
More from United States of America
- US imposes sanctions aiming to 'dismantle' International Criminal Court 31 sources
- Former Venezuelan president Nicolás Maduro could face new torture charges 24 sources
- US-German trio win Nobel medicine prize for work on optogenetics 21 sources
- Shinsegae backs Paramount’s Warner Bros. takeover with $1b 20 sources
- Japan summons US envoy as marine arrested over Okinawa murder 19 sources
- Trump targets Ilhan Omar at rally following raid on her home – US politics live 17 sources
- Nobel peace laureate Pillay calls ICC sanctions 'unacceptable' 15 sources
- One dead, several injured in incident involving Six Flags roller coaster in Georgia 15 sources